🔴 NeoGenomics is trading at 4.18% down in pre-market with no confirmed company-specific catalyst

NeoGenomics is trading 4.18% lower at $18.10, with no confirmed company-specific announcement or overnight catalyst explaining the decline. - The stock closed at $18.89 on September 22, 2026. - Recent coverage concerns Morgan Stanley commentary on NGS and MRD growth, not a new event. - Broader markets are only modestly lower; the move cannot be confidently attributed to market-wide sentiment. Confidence remains low pending additional disclosures.